Abstract

Hypoxia elicits endothelial dysfunction, in part, through reduced expression of endothelial nitric-oxide synthase (eNOS). Here we present evidence that hypoxia causes a rapid decrease in the transcription of the eNOS/NOS3 gene, accompanied by decreased acetylation and lysine 4 (histone H3) methylation of eNOS proximal promoter histones. Surprisingly, we demonstrate that histones are rapidly evicted from the eNOS proximal promoter during hypoxia. We also demonstrate endothelium-specific H2A.Z incorporation at the eNOS promoter and find that H2A.Z is also evicted by hypoxic stimulation. After longer durations of hypoxia, histones are reincorporated at the eNOS promoter, but these histones lack substantial histone acetylation. Additionally, we identify a key role for the chromatin remodeler, BRG1, in re-establishing eNOS expression following reoxygenation of hypoxic cells. We posit that post-translational histone modifications are required to maintain constitutive eNOS transcriptional activity and that histone eviction rapidly resets histone marks and is a proximal event in the hypoxic repression of eNOS. Although nucleosome eviction has been reported in models of transcriptional activation, the observation that eviction can also accompany transcriptional repression in hypoxic mammalian cells argues that eviction may be broadly relevant to both positive and negative changes in transcription.

Highlights

  • Institutes of Health Research (CIHR). ࡗ This article was selected as a Paper of the Week. □S The on-line version of this article contains supplemental Figs

  • We sought to determine whether decreased levels of histone H3 or H4 could account for the decrease in histone acetylation levels at the endothelial nitric-oxide synthase (eNOS) proximal promoter during hypoxia

  • The eNOS promoter is active in a variety of cell types when it is located in episomes [30], it is highly restricted in expression to endothelial cells when the promoter is integrated into chromatin [58]

Read more

Summary

EXPERIMENTAL PROCEDURES

Cell Culture and Hypoxia Model—Human umbilical vein endothelial cells (HUVEC) were cultured and characterized as described previously [25], and experiments were performed in early passage cells (passages 3– 4). Hypoxia experiments were performed using a ThermoForma (Marietta, OH) normobaric anoxia chamber that maintains less than 1% oxygen. This was established by the use of ultra-high purity gases (5% CO2, 10% H2, 85% N2, Praxair, Mississauga, Ontario, Canada). The BRG1, BRM, and control siRNAs were from Santa Cruz Biotechnology (sc29831, sc-29827, and sc-37007, respectively). Human eNOS mRNA was quantified using primers spanning the junction between exon 11 and 12: 5Ј-GGC ATC ACC AGG AAG AAG ACC-3Ј, 5Ј-TCA CTC GCT TCG CCA TCA C-3Ј, and probe 5Ј-FAMTM CCA ACG CCG TGA AGA TCT CCG C TAMRATM-3Ј. VEGFA mRNA levels were quantified using primers 5Ј-GCA GAC CAA AGA AAG ATA GAC CAA G-3Ј and 5Ј-CGC CTC GGC TTG TCA CAT-3Ј [28]. Primers used for chromatin accessibility real-time PCR analysis, pre-mRNA analysis, and chromatin immunoprecipitation

Primer name and location
RESULTS
DISCUSSION
ADDITIONS AND CORRECTIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call